These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24005626)

  • 1. [Regulatory role of NKT cells in the prevention of type 1 diabetes].
    Ghazarian L; Simoni Y; Pingris K; Beaudoin L; Lehuen A
    Med Sci (Paris); 2013; 29(8-9):722-8. PubMed ID: 24005626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
    Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
    Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of type 1 diabetes by NKT cells.
    Novak J; Griseri T; Beaudoin L; Lehuen A
    Int Rev Immunol; 2007; 26(1-2):49-72. PubMed ID: 17454264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
    Cardell SL
    Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.
    Hong S; Wilson MT; Serizawa I; Wu L; Singh N; Naidenko OV; Miura T; Haba T; Scherer DC; Wei J; Kronenberg M; Koezuka Y; Van Kaer L
    Nat Med; 2001 Sep; 7(9):1052-6. PubMed ID: 11533710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immunity in type 1 diabetes.
    Diana J; Gahzarian L; Simoni Y; Lehuen A
    Discov Med; 2011 Jun; 11(61):513-20. PubMed ID: 21712017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes.
    Chen YG; Choisy-Rossi CM; Holl TM; Chapman HD; Besra GS; Porcelli SA; Shaffer DJ; Roopenian D; Wilson SB; Serreze DV
    J Immunol; 2005 Feb; 174(3):1196-204. PubMed ID: 15661873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H2-D(d)-mediated upregulation of interleukin-4 production by natural killer T-cell and dendritic cell interaction.
    Mizuuchi K; Yanagawa Y; Iwabuchi K; Namba K; Kitaichi N; Ohno S; Onoé K
    Immunology; 2008 May; 124(1):102-11. PubMed ID: 18194275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NKT and tolerance.
    Diana J; Beaudoin L; Gautron AS; Lehuen A
    Methods Mol Biol; 2011; 677():193-206. PubMed ID: 20941612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preventive role of type 2 NKT cells in the development of type 1 diabetes.
    Sørensen JØ; Buschard K; Brogren CH
    APMIS; 2014 Mar; 122(3):167-82. PubMed ID: 23992281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of autoimmune disease by natural killer T cells.
    Sharif S; Arreaza GA; Zucker P; Mi QS; Delovitch TL
    J Mol Med (Berl); 2002 May; 80(5):290-300. PubMed ID: 12021841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
    Gallichan WS; Balasa B; Davies JD; Sarvetnick N
    J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation.
    Gigli G; Caielli S; Cutuli D; Falcone M
    Immunology; 2007 Nov; 122(3):409-17. PubMed ID: 17617156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD1d-restricted NKT regulatory cells: functional genomic analyses provide new insights into the mechanisms of protection against Type 1 diabetes.
    Mi QS; Meagher C; Delovitch TL
    Novartis Found Symp; 2003; 252():146-60; discussion 160-4, 203-10. PubMed ID: 14609217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10-conditioned dendritic cells prevent autoimmune diabetes in NOD and humanized HLA-DQ8/RIP-B7.1 mice.
    Tai N; Yasuda H; Xiang Y; Zhang L; Rodriguez-Pinto D; Yokono K; Sherwin R; Wong FS; Nagata M; Wen L
    Clin Immunol; 2011 Jun; 139(3):336-49. PubMed ID: 21458378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes.
    Zaccone P; Fehérvári Z; Jones FM; Sidobre S; Kronenberg M; Dunne DW; Cooke A
    Eur J Immunol; 2003 May; 33(5):1439-49. PubMed ID: 12731071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
    J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulation of autoimmunity by natural killer T cells.
    Linsen L; Somers V; Stinissen P
    Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the NKT cell hypothesis of human IDDM pathogenesis.
    Lee PT; Putnam A; Benlagha K; Teyton L; Gottlieb PA; Bendelac A
    J Clin Invest; 2002 Sep; 110(6):793-800. PubMed ID: 12235110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of immune responses by natural killer T cells.
    Sharif S; Delovitch TL
    Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 1():S23-31. PubMed ID: 11603866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.